Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Mylan Health Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (31)
Section 14, TGO91 consent (6)
Australian Public Assessment Report (AusPAR) (1)
Prescription medicine registration (1)

Date

2021 (2)
2020 (8)
2019 (1)
2018 (28)

Results for "[search-keyword]"

Search

Sponsor content

39 result(s) found, displaying 21 to 30

KLACID clarithromycin 500mg tablet bottle Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
ISOPTIN verapamil hydrochloride 160mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
ISOPTIN verapamil hydrochloride 120mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
KLACID clarithromycin 250mg tablet bottle Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
INFLUVAC inactivated influenza 0.5 mL vaccine syringe Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
KLACID HP7 omeprazole capsule, amoxicillin capsule, clarithromycin tablet composite pack carton Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
NORMATENS moxonidine 200 microgram tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
NORMATENS moxonidine 300 microgram tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
NORMATENS moxonidine 400 microgram tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
HYTRIN Terazosin 1mg (as hydrochloride dihydrate) and HYTRIN Terazosin 2mg (as hydrochloride dihydrate) tablet blister pack composite pack Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.